Concord Drugs Ltd.
BSE: 538965 | Sector: Health care |
NSE: N.A. | ISIN Code: INE858L01010 |
BSE 00:00 | 24 Jun | 21.25 |
-3.10 (-12.73%) |
OPEN
26.40 |
HIGH
26.40 |
LOW
19.50 |
NSE 05:30 | 01 Jan | Concord Drugs Ltd |
OPEN | 26.40 |
PREVIOUS CLOSE | 24.35 |
VOLUME | 5280 |
52-Week high | 37.40 |
52-Week low | 19.50 |
P/E | 11.68 |
Mkt Cap.(Rs cr) | 19 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Concord Drugs Ltd. (CONCORDDRUGS) - Latest News & Headlines
-
Concord Drugs Ltd Related Party Disclosure Under Regulation 23(9) Of SEBI(LODR) Regulation 2015
14/06/2022 | bse |
Downlaod PDF
-
Concord Drugs Ltd Announcement under Regulation 30 (LODR)-Resignation of Director
02/06/2022 | bse |
Downlaod PDF
-
Concord Drugs Ltd Audited Financial Results For Quarter And Financial Year Ended 31St March 2022.
30/05/2022 | bse |
Downlaod PDF
-
Concord Drugs Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
30/05/2022 | bse |
Downlaod PDF
-
Concord Drugs Ltd Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31.03.2022
17/05/2022 | bse |
Downlaod PDF
-
Jain Irrigation to merge global biz Temasek-owned Rivulis; stock zooms 17%
1.53 am | 23 Jun 2022 | Business Standard
Going forward Jain Irrigation Systems will focus on improving the India business to drive higher growth and margin in one of the fastest growing irrig...
-
Jain Irrigation to merge international biz with Temasek-backed Rivulis
11.03 pm | 21 Jun 2022 | Business Standard
The cash proceeds will be used to pay off Rs 2,700 crore of overseas debt
-
KPR Mill slips 9%, hits 52-week low as investors fret demand slowdown
12.30 pm | 21 Jun 2022 | Business Standard
With 24% correction in June, the stock of the garments & apparels maker has corrected 38% from its record high level of Rs 771.80
-
A straw in the wind from packaging company UFlex set to benefit FMCGs
10.09 am | 21 Jun 2022 | Business Standard
It is gearing up to make the six billion paper straws per annum needed by FMCG companies
-
Pidilite Industries stock gains on sales growth, margin recovery hopes
10.47 pm | 20 Jun 2022 | Business Standard
Easing raw material prices are a key trigger for the adhesive market leader
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices